JPRN-UMIN000017365招募中未知
The study for personnlized medicine using sorafenib with genome analysis - The study of sorafenib
Department of Pharmaceutical sciences, Tohoku university hospital0 个研究点目标入组 50 人开始时间: 2015年5月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
招募中
不适用
A research for personalized medicine using integrated database of ophthalmologic, environment and multi biometric information.Healthy and subjects with eye disorders (Age:20-70) who obtain informed consent.JPRN-UMIN000036747JST1,100
已完成
不适用
Study for personalized medicine based on pharmacokinetics and pharmacodynamics concerned with therapeutic drug of nontuberculous mycobacterium.JPRN-UMIN000020406Center for Infectious Disease and Infection Control10
进行中(未招募)
1 期
An exploratory study of sorafenib for patients listed for transplantation due to HCCPatients >18 years with hepatocellular carcinoma, on waiting list for liver transplantationMedDRA version: 12.1Level: LLTClassification code 10019829Term: Hepatocellular carcinoma recurrentMedDRA version: 12.1Level: LLTClassification code 10019830Term: Hepatocellular carcinoma resectableEUCTR2010-024306-36-SEVästra Götalandsregionen21
招募中
Unknown
A study of polymorphism on cognitive decline in elderly breast cancer patients.Breast CancerJPRN-UMIN000050415Aichi Cancer Center Hospital100
尚未招募
2 期
A clinical study on Parsiaoshan in treatment of kidney stoneCTRI/2021/03/032231Central Council of Unani Medicine New Delhi
